Highbridge Capital Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Highbridge Capital Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-201,043	Closed	-$4.21M	–	1836
2016 Q3	$4.21M	Buy	+201,043	New	+$2.32M	0.07%	290
2016 Q2	–	Sell	-108,314	Closed	-$718K	–	2015
2016 Q1	$718K	Buy	+108,314	New	+$985K	0.01%	844
2015 Q2	–	Sell	-35,315	Closed	-$414K	–	1863
2015 Q1	$414K	Buy	+35,315	New	+$476K	0.01%	1023

Highbridge Capital Management's VTAE Position: Q4 2016 in Review

Highbridge Capital Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 201,043 shares — an estimated $4.21M sold.

Highbridge Capital Management first reported a position in VTAE in Q1 2015 and held it in 3 quarters. The position peaked at $4.21M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Highbridge Capital Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Highbridge Capital Management sold 201,043 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $4.21M.
Highbridge Capital Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 3 quarters.
Highbridge Capital Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $4.21M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.